We just took a huge step forward toward scalable metabolic MRI and monitoring treatment responses in solid tumor oncology and beyond. Check out our preprint: https://lnkd.in/eCBBv679 At Vizma, we’re passionate about advancing technologies that break down barriers to clinical translation. This work underscores how streamlined solutions can unlock new possibilities—not just in preclinical imaging, but also as a foundation for expanding clinical applications. It’s innovations like these that push the boundaries of what’s possible in molecular imaging, paving the way for faster, more accessible diagnostic tools. Thank you to our incredible collaborators at the NC State Department of Chemistry, UNC Radiology, The MGH/HST Martinos Center for Biomedical Imaging, Wayne State University Department of Chemistry, University of York, and University of Pennsylvania Perelman School of Medicine. If you’re interested in discussing how these advancements can accelerate preclinical research or open new doors for clinical imaging, feel free to reach out.
Vizma Life Sciences
Hospitals and Health Care
Raleigh, North Carolina 140 followers
Visualize the future of health
About us
Committed to doing good science, making great products, and improving the health of the people that we love.
- Website
-
https://www.vizma.ai
External link for Vizma Life Sciences
- Industry
- Hospitals and Health Care
- Company size
- 11-50 employees
- Headquarters
- Raleigh, North Carolina
- Type
- Privately Held
Locations
-
Primary
Get directions
Raleigh, North Carolina, US
Employees at Vizma Life Sciences
-
Jeff Kovick
Raleigh-Durham Business Management Senior Director
-
Matthew Rosen
Director, Low Field MRI and Hyperpolarized Media Laboratory, MGH/Martinos Center for Biomedical Imaging.
-
Thomas Theis
Associate Professor of Chemistry, Physics and Biomedical Engineering
-
Patrick TomHon
Chief Scientific Officer @ Vizma.AI | Ph.D. in Physical Chemistry
Updates
-
We are thrilled to join this dynamic team of entrepreneurs and mentors! https://bit.ly/4dJswzw
Activation Capital has announced the selection of 10 fast-growing startups from across the country for the inaugural Frontier BioHealth program, which commenced with an in-person gathering on August 8-9, 2024! Each company will benefit from highly specialized training, targeted mentorship, and extensive relationship-building opportunities to accelerate its growth in the life sciences and healthtech sectors. Frontier BioHealth by Activation Capital is an educational and support program designed to provide highly specialized training, targeted mentorship, and relationship building to help scale pharmaceutical, biotech, medical device, and health-focused consumer products companies. As an independent nonprofit corporation operating on behalf of the Virginia Research Biotechnology Partnership Authority, Activation Capital is committed to advancing life sciences and other cutting-edge technologies through scientific research, commercialization, and ecosystem development. The innovative startups selected for Frontier BioHealth are Atticus, GenAssist, Gisens Biotech, KeViRx, Inc., Light Switch Bio, Oncoustics, OrthoPreserve, Pele Therapeutics, Rapid Forensic Cell Typing, Inc, and Vizma Life Sciences. “Frontier BioHealth embodies Activation Capital’s commitment to fostering innovation and entrepreneurship in the life sciences,” said Jim Pannucci, PhD, Vice President of Entrepreneurship at Activation Capital. “We are excited to see how these talented startups will leverage our resources and mentorship to make a significant impact in their fields. This program not only supports these innovative companies but also strengthens the Richmond entrepreneurial ecosystem, making it a thriving hub for future growth and success.” Funded (in part) through a grant with the U.S. Small Business Administration, the program offers access to a wide variety of resources from Activation Capital and its national-level partnerships with gener8tor, FedTech, and Fat Robin Consulting. Participants will benefit from tailored educational programming, expert coaching from global thought leaders and serial biomedical entrepreneurs, investor access, corporate partnerships, and fully funded travel to Richmond, VA. Read more about the 10 startups selected for the inaugural Frontier BioHealth program here: https://lnkd.in/gaZjintK #FrontierBioHealth #ActivationCapital #VABioTechPark #InnovationEcosystem #Innovation #Entrepreneurship #Startups #LifeSciences #Healthcare #Pharmaceutical #BioTech #MedicalDevice
Activation Capital Selects 10 Startups for Inaugural Frontier BioHealth Program - Activation Capital
https://activation.capital
-
Honored to be featured in North Carolina State University's latest campus news update. The article highlights our journey in commercializing cutting-edge chemistry research, particularly in the field of molecular imaging and metabolic MRI. Our work aims to revolutionize breast cancer treatment, potentially improving outcomes for countless patients. We're grateful for the recognition and excited about the future impact of our technology. Thank you, NCSU, for shining a light on the important intersection of academic research and real-world applications in healthcare. https://bit.ly/3ArKTdM #breastcancerawareness #MolecularImaging #MetabolicMRI
From the Lab to the Market: Commercializing Chemistry Research
https://sciences.ncsu.edu